2.79
price down icon3.79%   -0.11
after-market Handel nachbörslich: 2.79
loading

Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
49.89%
69.81
46.57 40.78 35.23 41.57
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
49.89%
-69.81
-46.57 -40.78 -35.23 -41.57
Income/Loss From Continuing Operations Before Tax
62.15%
-62.94
-38.81 -32.92 -27.93 -35.27
Income Tax Expense/Benefit
33.81%
0.231
0.349 0.221 0.251 0.197
Income/Loss From Continuing Operations After Tax
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Net Income/Loss
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Diluted Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Basic Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Diluted Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):